Previously the Live Forever Club — same community, now with a sharper mission for life extension

Infection Innovation Consortium (iiCON)

Liverpool-based consortium led by LSTM that links industry, academia and the NHS to develop new treatments and tests for infections

The Infection Innovation Consortium (iiCON) is a Liverpool-based research and development programme led by the Liverpool School of Tropical Medicine. Launched in 2020 with an £18.6m grant from UK Research and Innovation's Strength in Places Fund, it brings together industry, universities and the NHS to speed up the discovery and development of new anti-infective drugs, diagnostics, vaccines and preventive products.

Its core partners include LifeArc, Unilever, Evotec, Infex Therapeutics, the University of Liverpool and Liverpool University Hospitals NHS Foundation Trust. iiCON helped develop the £20m Liverpool Accelerate Laboratory, which uses robotics, AI and human organoids for infection research.

Visit website: https://www.infectioninnovation.com/

 infection-innovation-consortium

 iiconNW

 UCOLlvKAm0FIBIW5umefR6RA

See also

Liverpool School of Tropical Medicine (LSTM)

Liverpool institution founded in 1898 that researches and teaches tropical medicine and infectious diseases

Details last updated 05-Nov-2026

Infection Innovation Consortium (iiCON) News

Liverpool opens £20m robot lab to speed up drug and vaccine research

Liverpool opens £20m robot lab to speed up drug and vaccine research

BBC - 04-Sep-2026

Laboratory automation and mini organs aim to cut animal testing in Liverpool

People at Infection Innovation Consortium (iiCON)

Janet Hemingway

Founding director of the Infection Innovation Consortium (iiCON) and former director of the Liverpool School of Tropical Medicine

DoNotAge supplements affiliate link